LLY
$1,188.72+2.70%
as of close, Oct 7, 2026
☾ AH $1,188.72 +2.70%
Eli Lilly and CompanyStock · HealthcareS&P 500 1.5%US Stock Market 1.4%Russell 1000 1.4%Russell 3000 1.3%MSCI World 1.0%MSCI ACWI 0.9%S&P 500 Equal Weight 0.2%
LLY — Eli Lilly and Company price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED
200.0400.0600.0800.01000.01200.00200.0M$1188.72—20162019202120242026
2026-10-07
Price$1188.72
MA20$1130.53
MA50$1006.86
Vol8.5M
Key stats#
Price data
- Price
- $1,188.72
- YTD price return
- +10.61%
- YTD total return
- +11.15%
- Next earnings
- Oct 29, 2026 · Before open
- Market cap
- 1.1T
- Enterprise value
- 1.1T
- Shares outstanding
- 893.7M
- 52W low
- $783.85
- 52W high
- $1,292.65
- From 52W high
- -8.04%
- From 52W low
- +51.65%
- 52W range
- 80%
- Beta
- 0.50
Volume
- Rel volume
- 0.98×
- 30D volume
- 2.3M
- 30D $ vol
- 2.7B
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$16.0M
- Insider net 1Y
- −$358.5M
Form 4 transactions by trade date, as filed; latest on file 2026-08-17.
Fundamentals
- Sales (ttm)
- 79.7B
- Sales/share
- $89.14
- EPS (ttm)
- $29.79
- FCF (ttm)
- 16.8B
- FCF/share
- $18.81
- Book value/share
- $37.91
- Net margin
- 33.53%
- ROE
- 78.84%
- ROA
- 18.77%
- Debt / equity
- 1.41×
- Current ratio
- 1.35
Growth (CAGR, ttm) · 10Y
- Sales
- +49.62%+39.22%+24.42%+14.48%
- Net income
- +93.65%+60.18%+34.50%+26.91%
- Shares
- -0.68%-0.33%-0.37%-1.69%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +94.84%+60.60%+34.96%+29.08%
- Sales/share
- +50.64%+39.69%+24.88%+16.45%
- Book value/share
- +86.75%+45.69%+39.89%+10.63%
- Dividend/share
- +15.36%+15.25%+10.67%+12.72%
- Price
- +40.94%+28.08%+38.52%+30.74%
- Total return
- +41.83%+28.97%+39.78%+32.80%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 39.9×
- Fwd P/E
- 24.0×
- P/S (ttm)
- 13.3×
- P/B (mrq)
- 31.4×
- P/FCF (ttm)
- 63.2×
- EV/Sales (ttm)
- 13.9×
- FCF yield (ttm)
- 1.58%
- Dividend yield (fwd)
- 0.58%
- Dividend yield (ttm)
- 0.56%
- Dividend/share (fwd)
- $6.92
- Buyback yield (cash, ttm)
- 0.58%
- Shareholder yield (cash, ttm)
- 1.13%
Vs own 10Y history
- P/E
- 45th
- P/S
- 73rd
- P/B
- 47th
Bar = where today’s multiple sits in LLY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-07#
1D
+2.70%
5D
+2.73%
1M
+3.42%
3M
-3.79%
YTD
+10.61%
1Y
+40.91%
5Y
+409.79%
Recent filings#
- Aug 5Earnings · Earnings release — EPS $8.38 vs $6.01 est. (+39.4%); revenue $22.97B (+48% y/y) 4.9%
Financial statements
Open full LLY financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| JNJ | Johnson & Johnson | -6.10% | +1.44% |
| ABBV | AbbVie Inc. | +5.81% | +1.75% |
| MRK | Merck & Co. Inc. | -5.02% | +0.60% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -5.33% | -0.09% |
| TMO | Thermo Fisher Scientific Inc. | +7.87% | +0.83% |
| AMGN | Amgen Inc. | -5.52% | +2.60% |
| GILD | Gilead Sciences Inc. | -2.75% | +1.82% |
| ABT | Abbott Laboratories | -8.86% | +0.58% |
